Latest United States News

Zip delivered strong first-quarter growth, with total transaction volume up 18% to A$4.6 billion, but a US fraud event cost A$10.1 million and pushed group net bad debts higher. The company nevertheless reaffirmed its A$340 million FY27 cash EBTDA target, with September momentum offering an early test of whether the disruption was temporary.

Argent BioPharma ended the September quarter with just A$11,000 in cash after A$734,000 of operating outflows, despite retaining A$7.4 million of unused convertible financing capacity. The company is simultaneously expanding its commercial portfolio through NLC antiviral rights and a CannEpil veterinary programme.

Energy World has completed a major delivery milestone in its US$350 million turbine sale, receiving US$50 million and securing a further US$265 million in escrow. Most of the remaining proceeds still depend on inspection, refurbishment costs and final completion in early 2027.

Energy Technologies has outlined two signed commercial arrangements for its Cogenic laser display technology, including a SYNCH purchasing framework worth up to US$10 million and a 5% royalty licence with Amalgamated Vision. The opportunity is meaningful, but the SYNCH arrangement carries no minimum order commitment and still depends on product specifications, acceptance and purchase orders.

Recce Pharmaceuticals has granted Arrotex exclusive rights to commercialise its investigational RECCE 327 topical gel in Australia and New Zealand. The agreement offers a potential profit-share stream, but no upfront payments, sales forecast or approval have been disclosed.

Phoslock Environmental Technologies Limited (ASX:PET) reduced its September-quarter operating cash outflow to A$21,000 as sales receipts more than doubled from the previous quarter. The company has paused manufacturing in China after storage capacity was reached, while new lanthanum formulations and a first Phoslock 10 field trial move forward.

OD6 Metals has converted a run of high-grade Nevada fluorspar discoveries into a proposed 10,000-metre maiden drilling and bulk-sampling campaign. The company ended September with A$1.775 million in cash, but a subsequent A$6.92 million placement lifted pro forma funds to about A$8.695 million before costs and later movements.

Titomic has secured approval for a US$10.3 million direct loan from the US Export-Import Bank to fund a high-pressure cold-spray production cell in Huntsville, Alabama. The project is expected to expand US manufacturing capacity and support at least dozens of full-time jobs.

CSL has appointed ViiV Healthcare CEO Deborah Waterhouse to lead the biopharmaceutical group from 1 February 2027. Her arrival comes with a substantial UK-pound-denominated remuneration package and a mandate to renew the pipeline while simplifying operations.

Sierra Nevada Gold has started a 25,000-metre second-phase drilling campaign at its As Safra copper-gold project in Saudi Arabia, with the first assay results due in November. The company is directing capital and management attention to Saudi Arabia while exploring commercial options for its Nevada portfolio.

SenSen Networks has opened FY27 with record quarterly customer cash receipts of A$5.3 million, 17% annualised recurring revenue growth and positive operating cash flow. The ASX-listed AI enforcement software company also secured A$2.6 million in new and expansion contracts, although converting those wins into recurring revenue remains the next test.

InVert Graphite has secured outright ownership of Curtin University’s RapidPulse technology while advancing a 2.56 million tonne contained graphite resource at Kumba. The company ended September with A$3.2 million in cash, giving it an estimated 5.5 quarters of funding at the latest spending rate.